Literature DB >> 3611957

Total body bone mineral in healthy adults.

A Gotfredsen, A Hadberg, L Nilas, C Christiansen.   

Abstract

Total body bone mineral (TBBM) was measured by dual photon absorptiometry (DPA) using a gadolinium 153 source in 135 healthy women aged 21 to 77 years and 101 healthy men aged 20 to 74 years. Among several predictor variables, including lean body mass measured by DPA, weight, and height, only normalization for the projected skeletal area (i.e., calculation of the total body bone density) had an appreciable effect on reduction of TBBM variation. In regression analysis of TBBM, raw and normalized, vs. age, a menopause-adjusted age was used for interpretation of data in women. Regardless of the normalization procedure, the best fit of TBBM vs. menopause-adjusted age was obtained by a polynomial regression of the third degree or a combined linear (premenopausal)--exponential (postmenopausal) regression. In men bone loss was linear with age (0.2% to 0.3% per year). In women, no significant premenopausal bone loss was found. The postmenopausal exponential loss was 4%, 0.44%, and 0.03% per year from TBBM 1 year, 10 years, and 20 years after the menopause. This amounts to a negative calcium balance of 100 mg calcium per day during the first postmenopausal year, and returning to zero after 20 years of menopause, when about 20% of premenopausal bone is lost.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611957

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  Bone mass peak and incidence of osteoporosis and the Spanish Civil War.

Authors:  H Rico
Journal:  Calcif Tissue Int       Date:  1992-02       Impact factor: 4.333

2.  Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.

Authors:  Maurizio Civelli; Alessandro Piero Monici Preti; Valentina Cenacchi; Ivano Rondelli; Daniele Guastalla; Antoine Tarral; Philippe Dostert; Yann Guillevic; Marie-Claude Homery
Journal:  Br J Clin Pharmacol       Date:  2007-03-16       Impact factor: 4.335

3.  Total and regional bone mineral content in normal premenopausal women.

Authors:  H Rico; M Revilla; E R Hernandez; L F Villa; A Lopez-Alonso
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

4.  Age-related differences in total and regional bone mass: a cross-sectional study with DXA in 429 normal women.

Authors:  H Rico; M Revilla; L F Villa; M Alvarez de Buergo
Journal:  Osteoporos Int       Date:  1993-05       Impact factor: 4.507

5.  Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model.

Authors:  V Matkovic; T Jelic; G M Wardlaw; J Z Ilich; P K Goel; J K Wright; M B Andon; K T Smith; R P Heaney
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  The relationship of total body bone mineral (TBBMC) to anthropometric variables in postmenopausal women, and contribution of chronological age and years since menopause to TBBMC loss.

Authors:  H Rico; M Revilla; E R Hernandez; L Villa; M Alvarez del Buergo
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

7.  Rapid postmenopausal loss of total body and regional bone mass in normal southern Chinese females in Hong Kong.

Authors:  K K Pun; F H Wong; T Loh
Journal:  Osteoporos Int       Date:  1991-02       Impact factor: 4.507

8.  Bone mass in female cynomolgus macaques: a cross-sectional and longitudinal study by age.

Authors:  M J Jayo; C P Jerome; C J Lees; S E Rankin; D S Weaver
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

9.  A screening and counseling program for prevention of osteoporosis.

Authors:  B Gutin; M Peterson; T Galsworthy; M Kasper; R Schneider; J Lane
Journal:  Osteoporos Int       Date:  1992-09       Impact factor: 4.507

10.  Bone mineral content and anthropometric variables in men: a cross-sectional study in 324 normal subjects.

Authors:  H Rico; M Revilla; J Gonzalez-Riola; L F Villa; M Alvarez de Buergo
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.